Logo-npj
J Nephropharmacol. 2018;7(1): 32-35. doi: 10.15171/npj.2018.07

Original

Single dose thymoglobulin induction therapy in prevention of acute rejection in renal transplant
recipients

Georgi Abraham 1,2 * , Madhusudan Vijayan 2, Rajeevalochana Parthasarathy 1, Milly Mathew 1, Saravanan Sundararaj 1, Priyanka Koshy 1, Sam Nishanth 1, Kalpana Sakthivel 1

Cited by CrossRef: 1


1- Josi C, Parthasarathy A, Sundar D, Matthew M, Rajendran P, Abraham G. Our Unique Experience with Low-Dose Alemtuzumab as an Induction Agent for Renal Transplantation: A Case Series. 2024;18(4):440 [Crossref]